T (Thomsen-Friedenreich) and Tn epitope location and their spatial relations to adhesion plaques on human breast carcinoma cells: Immunogold-silver staining studies at scanning electron microscopic level

Journal of Submicroscopic Cytology and Pathology

Volumn 30, Issue 4, 1998, Pages 503-509

  Wang, B L ^a,c   Springer, G F ^a,b   Harwick, L C ^a  

^a The Chicago Medical College   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Adhesion plaque; Glycopratein; Human breast carcinoma cell; Immunogold silver staining; Scanning electron microscopy; T and Tn epitopes

Indexed keywords

BETA GALACTOSYL(1 3) N ACETYLGALACTOSAMINE; BETA-GALACTOSYL(1-3)-N-ACETYLGALACTOSAMINE; TN ANTIGEN; TUMOR ANTIGEN;

ARTICLE; BREAST TUMOR; CARCINOMA; CELL ADHESION; CELL CULTURE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BREAST NEOPLASMS; CARCINOMA; CELL ADHESION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; TUMOR CELLS, CULTURED;

EID: 0032175973     PISSN: 11229497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. ALLER C.T., SPRINGER G.F., TEGTMEYER H. and GILMAN-SACHS A., 1993. Decrease in naturally occurring serum anti-Tn antibodies (Abs) correlates positively with the expression of Tn epitope (EP) on the surface of B-cell chronic lymphocytic leukemia (B-CLL cells. J. Immunol., 150, 143A.
2. ANGLIN J.H. JR., LUNER M.P. and NORDQUIST R.E., 1977. Blood group-like activity released by human mammary carcinoma cells in culture. Nature, 269, 254-255.
3. BAND V. and SAGER R., 1989. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. USA, 86, 1249-1253.
4. BERGSTRAESSER L.M. and WEITZMAN S.A., 1993. Cultures of normal and malignant primary human mammary epithelial cells in a physiological manner simulates in vivo growth patterns and allows discrimination of cell type. Cancer Res., 53, 2644-2654.
5. BRAMWELL M.E., BHAVANANDAN V.P. WISEMAN G. and HARRIS H., 1983. Structure and function of the Ca antigen. Br. J. Cancer, 48, 177-183.
6. BRAY J., MACLEAN G.D., DUSEL F.J. and MCPHERSON T.A., 1982. Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: a correlation with disease burden. Clin. Exp. Immunol., 47, 176-182.
7. BROCKHAUSEN I., YANG J-M., BURCHELL J., WHITEHOUSE C. and TAYLOR-PAPADIMITRIOU J., 1995. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur. J. Biochem., 233, 607-617.
8. BURCHELL J. and TAYLOR-PAPADIMITRIOU J., 1993. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Epithelial Cell Biol., 2, 155-162.
9. BURRIDGE K. and CHRZANOWSKA-WODNICKA M., 1996. Focal adhesions, contractility, and signaling. Ann. Rev. Cell Dev. Biol., 12, 463-518.
10. BURRIDGE K., MOLONY L. and KELLY T., 1987. Adhesion plaques: sites of transmembrane interaction between the extracellular matrix and the actin cytoskeleton. J. Cell Sci. Suppl., 8, 211-229.
11. CLARK E.A. and BRUGGE J.S., 1995. Integrins and signal transduction pathways: the road taken. Science. 268, 233-239.
12. COON J.S., WEINSTEIN R.S. and SUMMERS J.L., 1982. Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am. J. Clin. Pathol., 77, 692-699.
13. DEVINE P.L. and MCKINZIE I.F.C., 1992. Mucins: Structure, function, and associations with malignancy. BioEssays, 14, 619-625.
14. FOTENOT J.D., TJANDRA N., BU D., HO C., MONTELARO R.C. and FINN O.J., 1993. Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core. Cancer Res., 53, 5386-5394.
15. FRESHNEY R.I., 1994. 'Culture of Animal Cells. A Manual of Basic Technique'. Wiley-Liss, Inc., New York, 3rd ed., pp. 133-135, 174, 254-262, 288-289.
16. HAKOMORI S-I., 1996. Tumor malignancy defined by aberrant glycosylation and sphyngo (glyco) lipid metabolism. Cancer Res., 56, 5309-5318.
17. HANISCH F-G, STADIE T. and BOSSLET K., 1995. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine with the VTSA Motif of MUC1 tandem repeats. Cancer Res., 55, 4036-4040.
18. HAREUVENI M., GAUTIER C., KIENY M-P., WRESCHNER D., CHAMBON P. and LATHE R., 1990. Vaccination against tumor cells expressing breast cancer epithelial tumor antigen. Proc. Natl. Acad. Sci., 87, 9498-9502.
19. HOWARD D.R. and TAYLOR C.R., 1980. An antitumor antibody in normal human serum: reaction of anti-T with breast carcinoma cells. Oncology, 37, 142-148.
20. LAFLAMME S.E. and AUER K.L., 1996. Integrin signaling. Semin. Cancer Biol., 7, 111-118.
21. LARSSON L-I., 1988. 'Immunocytochemistry: Theory and Practice'. CRC Press, Boca Raton, FL, pp 56, 105-112.
22. LAURENT J.C., NOËL P. and FAUCON M., 1978. Expression of a cryptic cell surface antigen in primary cell cultures from human breast cancer. Biomedicine, 29, 260-261.
23. MAGARIAN-BLANDER J., DOMENECH N. and FINN-O.J., 1993. Specific and effective T-cell recognition of cells transfected with a truncated human mucin cDNA. Ann. N.Y. Acad. Sci., 690, 231-243.
24. METCALFE S.M., SPRINGER G.F., SVVENNSEN R.J. and TEGTMEYER H., 1984. Monoclonal antibodies specific for human Thomsen-Friedenreich (T) and Tn blood group precursor antigens. In: 'Protides of Biological Fluids'. Peeters H. ed., Pergamon Press, Oxford, pp. 765-768.
25. NAKADA H., NUMATA Y., INOUE M., TANAKA N., KITAGAWA H., FUNAKOSHI I., FUKUI S. and YAMASHINA I., 1991. Elucidation of an essential structure recognized by an anti-GalNAc-Ser (Thr) monoclonal antibody (MLS 128). J. Biol. Chem., 266, 12402-12405.
26. SCHLEPPER-SCHÄFER J. and SPRINGER G.F., 1989. Carcinoma autoantigens T and Tn and their cleavage products interact with Gal/GalNAc-specific receptors on rat Kupffer cells and hepatocytes. Biochim. Biophy's. Acta. 1013, 266-272.
27. SCOPSI L., LARSSON L-I. BASTHOLM L. and NIELSEN M.H., 1986. Silver-enhanced colloidal gold probes as markers for scanning electron microscopy. Histochemistry, 86, 35-41.
28. SPRINGER G.F., 1984. T and Tn, general carcinoma autoantigens. Science, 224, 1198-1206.
29. SPRINGER G.F., 1989. Tn epitope (N-acetyl-D-galactosamine α-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. Mol. Immunol., 26, 1-5.
30. SPRINGER G.F., 1995. T & Tn pancarcinoma markers: autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma-detection and long-term breast carcinoma immunotherapy. Crit. Rev. Oncogen., 6, 57-85.
31. SPRINGER G.F., DESAI P.R. BANATWALA I., 1975. Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. J. Natl. Cancer Inst., 54, 335-339.
32. SPRINGER G.F., DESAI P.R., MURTHY M.S., TEGTMEYER H. and SCANLON E.F., 1979. Humun carcinoma-associated precursor antigens of the blood group MN system and the host's immune response to them. Prog. Allergy, 26, 42-96.
33. SPRINGER G.F., CHEINGSONG-POPOV R., SCHIRRMACHER V.,DESAI P.R. and TEGTMEYER H., 1983. Proposed molecular basis of murine tumor cell-heparocyte interaction. J. Biol. Chem., 258, 5702-5706.
34. SPRINGER G.F., TAYLOR C.R., HOWARD D.R., TEGTMEYER H., DESAI P.R., MURTHY S.M., FELDER B. and SCANLON E.F., 1985. Tn, a carcinomaassociated antigen, reacts with anti-Tn of normal human sera. Cancer, 55, 561-564.
35. SPRINGER G.F., CHANDRASEKARAN E.V., DESAI P.R. and TEGTMEYER H., 1988. Blood group Tn-active macromoleculcs from human carcinomas and erythrocytes: Characierization of and specific reactivity with mono-anJ polyclonal anti-Tn antibodies induced by various immunogens. Carbohydr. Res., 178, 271-292.
36. SPRINGER G.F., DESAI P.R., WISE W., CARLSTEDT S.C., TEGTMEYER H., STEIN R. and SCALON E.F., 1990. Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis. In: 'Immunodiagnosis of Cancer'. Herberman R.B. and Mercer D.W. eds., New York, Marcel Dekker, pp. 587-612.
37. STAMPEER M.R. and BARTLEY J.C., 1985. Induction of transformation and continuous cell lines from normal human mammary epithelial cells alter exposure to benzo[a]pyrene. Proc. Natl. Acad. Sci. USA, 82, 2394-2398.
38. STEIN R., CHEN S., GROSSMAN W. and GOLDENBERG D.M., 1989. Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen. Cancer Res., 49, 32-37.
39. TAYLOR-PAPADIMITRIOU J. and STAMPEER M.R., 1992. Culture of human mammary epithelial cells. In: 'Culture of Epithelial Cells'. Freshney R.I. ed., Wiley-Liss, Inc., NY, pp. 107-133.
40. TAYLOR-PAPADIMITRIOU J. and EPENETOS A.A., 1994. Exploiting altered glycosylation patterns in cancer: Progress and challenges in diagnosis and therapy. Trends Biotechnol., 12, 227-233.
41. TAYLOR-PAPADIMITRIOU J., BERDICHEVSKY F., D'SOUZA B. and BURCHELL J., 1993. Human models of breast cancer. Cancer Surv.: The Mol. Pathol. Cancer, 16, 19-78.
42. Wang B.L., SCOPSI L., NEILSEX M.H. and LARSSON L-I., 1985. Simplilied purification and testing of colloidal gold probes. Histochemistry, 83, 109-115.
43. WANG, B.L., SPRINGER G.F. and CARLSTEDT S.C., 1997. Quantitative computerized image analysis of Tn and T (Thomsen-Friedenreich) epitopes in prognostication of human breast carcinoma. J. Histochem. Cytochem., 45, 1393-1400.
44. YAMASHITA Y., CHUNG Y.S., HORIE R., KANNAGI R. and SOWA M., 1995. Alterations in gastric mucin with malignant transformation: novel pathway for mucin synthesis. J. Natl. Cancer Inst., 87, 441-446.
45. YUAN M., ITZKOWITZ S.H., BOLAND C.R., KIM Y.D., TOMITA J.T., PALEKAR C., BENNINGTON J.L., TRUMP B.F. and KIM Y.S., 1986. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res. 46, 4841-4847.
46. ZETTER B.R. and KUNDRA V., 1994. Regulation of metastatic tumor spread. Resident & Staff Physician, 40, 39-43.